Metronidazole Morningside Healthcare

Metronidazole, the active ingredient in Metronidazole Morningside Healthcare, is a nitroimidazole antibiotic presented as an oral dosage form for systemic use. It treats infections caused by anaerobic bacteria and certain protozoa, including bacterial vaginosis, trichomoniasis, amoebiasis and other anaerobic bacterial infections in adult patients and is indicated for use in both outpatient and inpatient settings.

GNH USA supplies Metronidazole Morningside Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Metronidazole is used to treat infections caused by anaerobic bacteria and susceptible protozoa.

- Bacterial vaginosis: eradicates the anaerobic bacteria responsible, relieving discharge and odor. - Trichomoniasis: eliminates Trichomonas vaginalis, resolving genital irritation. - Amoebiasis: destroys Entamoeba histolytica trophozoites, treating intestinal and extra‑intestinal disease. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, pelvic and skin‑soft tissue infections.

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: persistent metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhoea: loose stools, sometimes with abdominal cramping.

Serious or Rare Side Effects: - Seizures: convulsive episodes, especially with high plasma levels. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before prescribing metronidazole, consider the following precautions to ensure safe use.

- Pregnancy: consult a healthcare professional; safety not established. - Alcohol consumption: avoid alcohol during therapy and for at least 48 hours after the last dose. - Renal impairment: dose adjustment may be required in patients with reduced kidney function. - Hepatic disease: use with caution in patients with liver dysfunction. - Drug interactions: review all concomitant medications for potential interactions. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Metronidazole can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction. - Warfarin: can enhance anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced. - Phenytoin: metronidazole may lower phenytoin levels.